The grant application process is now open for continuing education (CE) activities that are compliant with the Opioid Analgesic Risk Evaluation and Mitigation Strategy (OA REMS). The 2023 CE Request for Application (RFA) is available here. Submissions are due by March 9, 2023 (11:59 pm ET).
The goal of the grants is to support high-quality REMS-compliant accredited continuing education for prescribers and other healthcare professionals on the treatment and monitoring of patients with pain.
To be eligible, the continuing education must be based solely on the Opioid Analgesics REMS Education Blueprint for Health Care Providers Involved in the Treatment and Monitoring of Patients with Pain that was approved by the US FDA in September 2018.
